Impetigo Treatment
For impetigo, topical mupirocin 2% ointment applied three times daily for 5-7 days is the first-line treatment for localized infections, while oral antibiotics such as clindamycin (300mg three times daily for 7-10 days) are recommended for extensive disease. 1
Types of Impetigo
Nonbullous impetigo (70% of cases)
Bullous impetigo (30% of cases)
Treatment Algorithm
1. Localized Infection (Limited Lesions)
- First-line: Topical antibiotics
2. Extensive Disease (Multiple Lesions or Widespread)
- Oral antibiotics for 7-10 days:
Special Considerations
Pediatric Patients
- Mupirocin has shown 78-96% clinical efficacy in pediatric populations 3
- Avoid tetracyclines (doxycycline, minocycline) in children under 8 years due to risk of inhibiting bone growth 1
- For hospitalized children with complicated infections, vancomycin is first choice, followed by clindamycin and linezolid 1
Treatment Duration and Response
- Typical duration: 5-7 days for topical therapy, 7-10 days for oral therapy 1
- Evaluate clinical response within 48-72 hours of starting therapy 1
- If no improvement within 3-5 days:
- Consider bacterial culture and sensitivity testing
- Evaluate for alternative diagnosis
- Consider need for intravenous antibiotics 1
Prevention and Hygiene Practices
- Keep lesions covered when possible
- Use separate towels and linens
- Practice good hand hygiene
- Avoid sharing personal items
- Limit exposure to infected individuals 1
Common Pitfalls to Avoid
- Failure to consider MRSA in recalcitrant cases 1
- Using penicillin alone, which is inferior to other antibiotics for impetigo 1, 4
- Inadequate treatment duration 1
- Relying solely on topical therapy for extensive disease 1
- Using topical disinfectants, which are inferior to antibiotics 2, 5
- Not addressing underlying conditions that may predispose to recurrent infection 1
- Using trimethoprim-sulfamethoxazole alone when streptococcal infection is suspected (inadequate coverage) 1
Remember that impetigo typically resolves within 7-10 days with appropriate treatment, and complications such as poststreptococcal glomerulonephritis are rare (<1 case/1,000 population per year) 1.